Catch up on the top radiology content of the past week.
|Articles|September 27, 2000
Marconi appoints product strategies VP
Marconi Medical Systems has promoted Eliezer Tokman to senior vice president for product strategies, where he will help define the company’s overall market opportunities, including new technologies, clinical applications, joint ventures, and
Advertisement
Marconi Medical Systems has promoted Eliezer Tokman to senior vice president for product strategies, where he will help define the companys overall market opportunities, including new technologies, clinical applications, joint ventures, and other strategic alliances.
Tokman joined Marconi in 1998, when the company acquired Elscint. He had been president of Elscint America. During his career with the Israel-based company, Tokman was instrumental in developing its multislice CT product.
After the merger, Tokman assumed the role of Marconis director of Global CT Engineering until promoted to his new position.
Advertisement
Related to this article
Reportedly one of the first FDA-cleared chest X-ray AI software platforms derived from a foundation model, the Chest Xray software facilitates detection and localization of lung nodules, pneumothorax, mediastinal abnormalities and other thoracic abnormalities.
Incorporating structural MRI to improve PET imaging resolution, the MICSI-PET software also offers automated Centiloid quantification from amyloid PET scans.
Emerging research demonstrates the increasing stability of attenuation on clinically relevant VMIs with photon-counting CT and a redefined role of kV that may have implications for longitudinal quantitative CT.
For patients with intermediate-risk prostate cancer, those with lower apparent diffusion coefficient (ADC) values on pre-treatment DWI MRI had a fourfold higher prevalence of distant metastasis in a study with a 10.3-year median follow-up.
In the second of a two-part podcast episode, Lauren Nicola, MD, Christoph Wald, MD, PhD, MBA, and Peter Shen discuss challenges with evaluating value and ROI for AI software, the physician time required to do so, and possible solutions to facilitate improved clarity and consistency with AI reimbursement.
In the latest episode of her “Breast Imaging in Focus” series, Manisha Bahl, MD, MPH, FSBI, offer pertinent takeaways for breast radiologists from recently issued guidelines for addressing proliferative breast lesions with atypia and lobular carcinoma in situ (LCIS).
In a study involving over 2,800 people who had brain MRI scans, researchers found that people in the most disadvantaged neighborhoods had 37 percent higher white matter hyperintensity volume (WMHV) on average in comparison to people in the least disadvantaged areas.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears Software That Combines MRI Enhancement of PET Imaging with Automated Quantification of Amyloid and Tau PET
2
Diagnostic Imaging’s Weekly Scan: September 13 — September 19
3
Foundation Model-Based Chest X-Ray AI Software Gets FDA Nod
4
Prostate MRI Study Links Lower ACD Values on DWI to Higher Long-Term Risk of Distant Metastases
5